Today is the final day of the meeting! Read today's Daily News for highlights from Day 2 and expert commentary on studies presented during yesterday's Oral Abstract session.
Expert commentary on a study that compared clinical, quality-of-life, and treatment-related cost outcomes for patients with early-stage NSCLC receiving surgery or SBRT.
Commentary on two studies from Virginia Commonwealth University and Yale University that highlight this issue and try to provide some guidelines for midrange doses for lung radiotherapy and esophageal dose.
SITC's Cancer Immunotherapy Winter school is set to provide early-to-mid career scientists and clinicians with cutting-edge education and a transformative experience. Join in Austin, Texas, or virtually!
